{"gene":"TNFAIP6","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1993,"finding":"TSG-6 gene is transcriptionally activated by TNF-α and IL-1 as a primary response gene in human fibroblasts; the TSG-6 gene was mapped to human chromosome 2 and its promoter region contains NF-IL6, AP-1, and IRF binding sites that mediate cytokine-induced transcription. Deletion analysis showed a region from -165 to -58 bp confers IL-1/TNF inducibility.","method":"Nuclear run-on transcription assay, Southern blot, primer extension, deletion analysis with CAT reporter gene transfection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods in a single rigorous study defining promoter elements","pmids":["8454591"],"is_preprint":false},{"year":1995,"finding":"Activation of the TSG-6 promoter by NF-IL6 requires two functionally interdependent adjacent NF-IL6 binding sites (at positions -106 to -114 and -92 to -83); mutation of either site greatly decreased or abolished NF-IL6-driven transcription.","method":"Footprinting, EMSA, site-directed mutagenesis, reporter gene (CAT) transfection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with EMSA and functional reporter assay","pmids":["7876106"],"is_preprint":false},{"year":1997,"finding":"TSG-6 forms a stable covalent complex (~120 kDa) with the serum protease inhibitor inter-alpha-inhibitor (IαI) and potentiates IαI's anti-plasmin activity, constituting a mechanism for TSG-6's anti-inflammatory effects via modulation of the protease network.","method":"Biochemical complex isolation, anti-plasmin activity assay, SDS-PAGE","journal":"Cytokine & growth factor reviews","confidence":"Medium","confidence_rationale":"Tier 3 — biochemical characterization in a review but summarizing direct experimental data; replicated in subsequent studies","pmids":["9244409"],"is_preprint":false},{"year":1997,"finding":"The Link module of TSG-6 binds hyaluronan and chondroitin-4-sulphate at overlapping sites, but does not bind chondroitin-6-sulphate or heparin; this was determined by microtiter plate-based binding assays and competition experiments.","method":"Microtiter plate binding assay with biotinylated hyaluronan and biotinylated Link module, competition experiments","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — direct binding assay with competition experiments establishing ligand specificity","pmids":["9237673"],"is_preprint":false},{"year":1998,"finding":"TSG-6 binds hyaluronan and aggrecan through a common binding surface in a pH-dependent manner, with maximal binding at pH 6.0 and dramatic loss of function at higher pH, suggesting TSG-6 activity is regulated by pH gradients in inflamed cartilage.","method":"Microtiter plate binding assays at different pH values, competition experiments with hyaluronan","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro binding assays with mechanistic interpretation","pmids":["9654129"],"is_preprint":false},{"year":2000,"finding":"The HA-binding site on the Link module of TSG-6 was localized by NMR spectroscopy to residues Lys11, Tyr59, Asn67, Phe70, Lys72, and Tyr78, and isothermal titration calorimetry showed that a single Link module is sufficient for high-affinity HA binding (KD ~0.2–0.5 μM for HA oligomers ≥6-mers).","method":"NMR spectroscopy (chemical shift perturbation), isothermal titration calorimetry","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — structure-based mapping with calorimetric validation","pmids":["10903951"],"is_preprint":false},{"year":2001,"finding":"TSG-6 co-localizes with IαI and hyaluronan in the cumulus-oocyte complex extracellular matrix, and Western blot confirmed the presence of both free TSG-6 and TSG-6/IαI complexes in ovulated COCs, suggesting TSG-6 has a structural role in COC matrix formation possibly by cross-linking HA molecules via IαI.","method":"Immunofluorescence, laser confocal microscopy, Western blot","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with protein complex detection, consistent with functional context","pmids":["11420253"],"is_preprint":false},{"year":2002,"finding":"The isolated recombinant Link module of TSG-6 (Link_TSG6) inhibits neutrophil migration in vivo equivalently to full-length protein in an HA-binding and IαI-complex-independent manner; mutagenesis of six residues showed this anti-inflammatory activity is entirely within the Link module but is not dependent on HA binding or potentiation of IαI anti-plasmin activity.","method":"In vivo murine air pouch model, in vitro anti-plasmin assay, site-directed mutagenesis of Link module, recombinant protein production in Drosophila expression system","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with in vivo and in vitro functional assays","pmids":["12401803"],"is_preprint":false},{"year":2002,"finding":"Replacement of the CD44 Link module with the TSG-6 Link module (higher HA affinity) converted rolling leukocyte behavior to firm tethering under flow, demonstrating that the low intrinsic HA affinity of CD44's Link module (relative to TSG-6's) is mechanistically important for leukocyte rolling.","method":"CD44/TSG-6 chimera expression in cells, parallel plate flow assay, hyaluronan binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in chimeric protein with functional flow assay","pmids":["12011075"],"is_preprint":false},{"year":2004,"finding":"TSG-6 preincubation with hyaluronan enhances or induces CD44-mediated HA binding on lymphoid cells; this is mediated through the Link module's HA-binding function and may involve TSG-6-mediated HA cross-linking that promotes receptor clustering and increases binding avidity.","method":"Cell binding assays, CD44-blocking antibodies, CD44-negative cell controls, flow assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal functional experiments with blocking antibodies and CD44-negative controls","pmids":["15060082"],"is_preprint":false},{"year":2004,"finding":"TSG-6-knockout mice show enhanced neutrophil extravasation, elevated plasmin/myeloperoxidase/neutrophil elastase activities in inflamed joints, and more severe proteoglycan-induced arthritis, demonstrating that endogenous TSG-6 inhibits neutrophil extravasation and protease activity at inflammatory sites.","method":"TSG-6 knockout mouse, proteoglycan-induced arthritis model, thioglycollate peritonitis model, enzyme activity assays","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple disease models and molecular readouts, replicated with recombinant protein rescue","pmids":["15457471"],"is_preprint":false},{"year":2004,"finding":"The TSG-6 Link module inhibits leukocyte rolling, adhesion, and emigration in IL-1β–inflamed mesenteries in vivo, and inhibits neutrophil transmigration across endothelial monolayers in vitro, without affecting neutrophil chemotaxis or endothelial cell activation directly.","method":"Intravital microscopy of mouse mesentery, in vitro neutrophil transmigration assay","journal":"Microcirculation","confidence":"High","confidence_rationale":"Tier 2 — in vivo and in vitro assays with mechanistic dissection","pmids":["15513871"],"is_preprint":false},{"year":2005,"finding":"TSG-6 acts as a cofactor and catalyst (transferase) for the formation of heavy chain-HA (HC·HA) complexes: it forms covalent HC·TSG-6 intermediates (TSG-6·HC1 and TSG-6·HC2) via transesterification from IαI chondroitin sulfate, then transfers HCs onto HA in a second metal ion-dependent (Mg2+ or Mn2+; inhibited by Co2+) transesterification; TSG-6 is then recycled.","method":"In vitro reconstitution with purified IαI and recombinant TSG-6, SDS-PAGE, metal ion substitution/chelation experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with purified components, mechanistic dissection of reaction steps","pmids":["15840581"],"is_preprint":false},{"year":2005,"finding":"The N-terminal module of thrombospondin-1 (TSP1) binds directly to the Link module of TSG-6 (KD comparable to TSG-6's GAG interactions); heparin (bound to TSP1) inhibits the interaction. TSP1 enhances covalent HC·TSG-6 formation and subsequent HC transfer onto HA.","method":"Radioligand binding assay (125I-TSP1), recombinant domain mapping, heparin/hyaluronan competition, in vitro HC transfer assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct binding assay with multiple recombinant domains and functional HC transfer reconstitution","pmids":["16006654"],"is_preprint":false},{"year":2005,"finding":"Full-length TSG-6 binds hyaluronan to form a stable, dissociation-resistant complex in a temperature-dependent manner; TSG-6 also binds all chondroitin sulfate isoforms under physiological conditions. TSG-6 binding to immobilized HA does not block subsequent lymphoid cell adhesion to HA.","method":"Protein-HA binding assay with dissociating agents, temperature dependence, cell adhesion assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical binding assays with multiple glycosaminoglycans","pmids":["15699048"],"is_preprint":false},{"year":2005,"finding":"NMR spectroscopy combined with molecular modeling defined the HA-binding groove of the TSG-6 Link module in detail: two adjacent tyrosine residues form CH-π stacking interactions with HA sugar rings, acetamido groups of GlcNAc fit into hydrophobic pockets providing HA selectivity over other polysaccharides, and two basic residues form salt bridges with glucuronic acids.","method":"NMR spectroscopy with 13C/15N-labeled HA, molecular docking, sequence alignment/homology modeling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with mechanistic validation","pmids":["15718240"],"is_preprint":false},{"year":2006,"finding":"Two-step mechanism for HC·TSG-6 complex formation: (1) a cation-independent non-covalent interaction between TSG-6 and the chondroitin sulfate chain of IαI (KD ~180 nM at site 1); (2) a cation-dependent (Mn2+, Mg2+, or Ca2+) transesterification generating the covalent HC·TSG-6 cross-link at a distinct site 2; intact native folds of both IαI and TSG-6 and an intact chondroitin sulfate chain are required.","method":"In vitro reconstitution with purified proteins, divalent cation manipulation, limited proteolysis, chondroitin sulfate cleavage","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with mechanistic dissection of two-step reaction","pmids":["16768462"],"is_preprint":false},{"year":2006,"finding":"Heparin binding to TSG-6's Link module inhibits subsequent HA binding even though heparin binds a distinct site from HA, revealing allosteric communication between the heparin-binding and HA-binding sites; pH also modulates binding to HA, heparin, and protein ligands, suggesting differential partitioning of TSG-6 function in different tissue microenvironments.","method":"Binding competition assays, pH variation studies, glycosaminoglycan specificity profiling","journal":"Biochemical Society transactions","confidence":"Medium","confidence_rationale":"Tier 2 — functional binding studies with mechanistic interpretation; confirmed by subsequent NMR work","pmids":["16709183"],"is_preprint":false},{"year":2007,"finding":"The pH-dependent interaction of TSG-6 with HA is mechanistically mediated by His4: upon deprotonation above pH 6.0, His4 disrupts a salt bridge with buried Asp89, which is simultaneously hydrogen-bonded to key HA-binding residue Tyr12, thereby reducing HA affinity. His45 is responsible for affinity gain between pH 3.5 and 6.0.","method":"Site-directed mutagenesis, NMR (pKa determination, folding profiles), isothermal titration calorimetry, microtiter plate assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with NMR and ITC, defining a molecular mechanism","pmids":["17307731"],"is_preprint":false},{"year":2007,"finding":"X-ray crystallography and 15N NMR relaxation of the TSG-6 Link module revealed high mobility in the β4/β5 loop and at the Cys47-Cys68 disulfide bond (both HA-binding regions) in the free protein; HA binding dampens this mobility. Lys54 (heparin-binding site) becomes less mobile when HA is bound, providing evidence for allostery between the HA and heparin-binding sites.","method":"X-ray crystallography, 15N NMR relaxation, heparin docking calculations","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with NMR dynamics and mutagenesis-informed docking","pmids":["17585936"],"is_preprint":false},{"year":2008,"finding":"TSG-6 inhibits RANKL-induced osteoclast differentiation/activation and BMP-2-mediated osteoblast differentiation via direct binding to RANKL and BMP-2 (but not BMP-3) through composite surfaces involving both its Link and CUB modules; TSG-6-knockout mice have elevated trabecular bone mass in unchallenged conditions.","method":"In vitro osteoclast and osteoblast differentiation assays, direct protein-protein binding (interaction analysis), TSG-6 KO mouse bone phenotype","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct binding combined with KO mouse phenotype and domain mapping","pmids":["18586671"],"is_preprint":false},{"year":2008,"finding":"Confocal FRAP demonstrated that the TSG-6 Link module binds polymeric HA with maximal affinity at pH 6.0 (100-fold higher affinity than at pH 7.4), while aggrecan G1 has maximal binding at pH 7.0–8.0, explaining their differential roles in normal versus inflamed cartilage.","method":"Confocal fluorescence recovery after photobleaching (FRAP) with labeled proteins","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative biophysical method defining affinity and pH dependence","pmids":["18806261"],"is_preprint":false},{"year":2008,"finding":"HC transfer from bikunin proteins to HA requires both TSG-6 and HC2: HC2 (from IαI, HC2.bikunin, or free HC2) promotes formation of HC3·TSG-6 and subsequently HC3·HA complexes; HC1 or HC3 alone cannot perform this role.","method":"In vitro reconstitution with purified components from human plasma, SDS-PAGE identification","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with biochemical identification of the required co-factor","pmids":["18448433"],"is_preprint":false},{"year":2009,"finding":"Intravenously infused human MSCs become trapped as emboli in the lung and are activated to upregulate TSG-6 expression; TSG-6 knockdown (siRNA) in hMSCs abolishes the reduction of infarct size and inflammatory responses after myocardial infarction, and recombinant TSG-6 alone replicates the therapeutic effect.","method":"Quantitative human DNA/mRNA tracking in tissues, TSG-6 siRNA knockdown in hMSCs, recombinant TSG-6 administration, mouse myocardial infarction model","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — siRNA knockdown plus recombinant protein rescue in a disease model, replicated across multiple experimental arms","pmids":["19570514"],"is_preprint":false},{"year":2011,"finding":"TSG-6 interacts with CD44 on resident peritoneal macrophages to decrease zymosan/TLR2-mediated nuclear translocation of NF-κB, establishing a CD44-dependent mechanism by which TSG-6 reduces macrophage-driven inflammation.","method":"Zymosan-induced peritonitis model, NF-κB nuclear translocation assay, CD44 interaction studies","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway (TSG-6 → CD44 → TLR2/NF-κB) defined in vivo and in vitro","pmids":["21551236"],"is_preprint":false},{"year":2011,"finding":"Full-length TSG-6 cross-links HA via HA-induced TSG-6 oligomerization (positive cooperative binding); the TSG-6 oligomers act as cross-linkers that condense and rigidify HA films. The isolated Link module alone binds HA without cooperativity and with lower affinity and cannot cross-link HA.","method":"End-grafted HA films, quartz crystal microbalance, surface-sensitive biophysical techniques (QCM-D, reflectometry), atomic force microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted biophysical system with multiple orthogonal surface techniques establishing cooperativity and cross-linking","pmids":["21596748"],"is_preprint":false},{"year":2011,"finding":"TSG-6 inhibits RANKL-mediated osteoclast activation via an autocrine mechanism: osteoclast precursors and mature osteoclasts produce TSG-6 in response to TNFα, IL-1, and IL-6, and anti-TSG-6 antibody increases lacunar resorption. TSG-6 acts synergistically with osteoprotegerin.","method":"Osteoclast differentiation/resorption assays, anti-TSG-6 neutralizing antibody, ELISA for TSG-6 in conditioned media and synovial fluid","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 — antibody neutralization of endogenously produced TSG-6 with functional readout, combined with protein quantification","pmids":["21162099"],"is_preprint":false},{"year":2012,"finding":"TSG-6 amplifies hyaluronan synthesis by airway smooth muscle cells: when added together with poly(I:C), TSG-6 increases HA accumulation in the cell-associated matrix and induces HA synthesis, an effect absent with TSG-6 alone. This occurs via a mechanism independent of TSG-6, HAS1/3, or CD44 on the smooth muscle cells themselves.","method":"Airway smooth muscle cell cultures from TSG-6−/−, HAS1/3−/−, and CD44−/− mice, HA accumulation assays, poly(I:C) stimulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple knockout cell lines used to dissect mechanism","pmids":["23129777"],"is_preprint":false},{"year":2013,"finding":"IαI impairs TSG-6-induced HA cross-linking: in the presence of IαI, TSG-6-mediated cross-linking and condensation of HA films is suppressed, and this suppresses TSG-6-mediated enhancement of HA binding to CD44-positive cells. Two types of TSG-6/IαI complexes form on HA: covalent HC·TSG-6 (weakly bound to HA) and a novel noncovalent HA-stable complex.","method":"End-grafted HA films, surface-sensitive biophysics (QCM-D, reflectometry), CD44-positive cell binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted biophysical system revealing regulatory interplay between IαI and TSG-6 functions","pmids":["24005673"],"is_preprint":false},{"year":2013,"finding":"Assembly of MSCs into spheres activates caspase-dependent IL-1α/β signaling, which drives upregulation of TSG-6, STC1, and COX2/PGE2. Inhibitors of caspases reduce IL-1A/B expression; inhibitors of IL-1 signaling decrease TSG-6 and PGE2 production and negate anti-inflammatory effects on macrophages.","method":"Hanging drop sphere cultures, caspase inhibitors, IL-1 signaling inhibitors, Notch inhibitors (γ-secretase), gene expression profiling","journal":"Stem cells","confidence":"High","confidence_rationale":"Tier 2 — pharmacological pathway dissection with multiple inhibitors and functional readout","pmids":["23922312"],"is_preprint":false},{"year":2014,"finding":"TSG-6 directly binds CXCL8 (KD ~25 nM) at the CXCL8 glycosaminoglycan-binding site via the TSG-6 Link module, antagonizing CXCL8-heparin association, impairing CXCL8 binding to cell-surface glycosaminoglycans, blocking CXCL8 transcytosis across endothelial monolayers, and suppressing CXCL8-stimulated neutrophil transendothelial migration.","method":"SPR/binding affinity measurement, neutrophil transendothelial migration assay, CXCL8-heparin competition assay, CXCL8 cell-surface binding assay, transcytosis assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — direct binding with KD measurement plus multiple functional assays","pmids":["24501198"],"is_preprint":false},{"year":2014,"finding":"TSG-6 refined NMR-based model of the Link module-HA complex: HA makes more extensive contacts than previously thought; a glucuronic acid ring makes stacking and ionic interactions with a histidine and lysine, causing HA to bend around two faces of the Link module in a manner resembling CD44-HA interaction. The HA-binding site is NOT used for recognition during HC transfer onto HA.","method":"NMR spectroscopy with 10 distinct HA oligosaccharides (4- to 8-mers), 13C-labeled octasaccharide, chondroitin/HA hybrid oligomers, TSG-6 mutant analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structural study with novel reagents and functional mutant validation","pmids":["24403066"],"is_preprint":false},{"year":2014,"finding":"TSG-6 inhibits LPS-induced NF-κB and MAPK pathway activation in BV2 microglial cells in a CD44-dependent manner; knockdown of CD44 in BV2 cells abrogated TSG-6-mediated inhibition of pro-inflammatory gene expression and NF-κB/MAPK activation.","method":"LPS-stimulated BV2 microglial cell culture, TSG-6 treatment, CD44 siRNA knockdown, NF-κB/MAPK pathway analysis by Western blot","journal":"Journal of neuroinflammation","confidence":"High","confidence_rationale":"Tier 2 — pathway mechanistic dissection with receptor knockdown","pmids":["25088370"],"is_preprint":false},{"year":2015,"finding":"The TSG-6 CUB module structure was determined, revealing a calcium ion-binding site with a chelating glutamic acid residue that mediates formation of HC·TSG-6 intermediates via an initial metal ion-dependent noncovalent interaction between TSG-6 and HCs (also requiring an HC-associated Mg2+). The Link module HA-binding site is not required for HC transfer onto HA; only TSG-6 transferase activity (not HA binding) is essential for COC expansion.","method":"Crystal structure determination of CUB module, TSG-6 mutant analysis (transferase-impaired and HA-binding-impaired), in vitro COC expansion assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis and functional reconstitution in COC expansion assay","pmids":["26468290"],"is_preprint":false},{"year":2015,"finding":"TSG-6 in muscle injury microenvironments is required for MSC engraftment: TSG-6 produced by MSCs in response to injury signals (C2C12 myotube lysate) promotes formation of SHAP-HA complexes (covalent HC·HA) that are required for MSC settlement in skeletal muscle; TSG-6 shRNA knockdown prevents settlement.","method":"Mouse MSC transplantation model, TSG-6 shRNA knockdown, immunofluorescence co-localization of HA/IαI/TSG-6, in vitro stimulation with C2C12 lysate","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — shRNA knockdown with in vivo transplantation functional readout","pmids":["26178374"],"is_preprint":false},{"year":2016,"finding":"TSG-6 (via its Link module) binds multiple CC and CXC chemokines (CXCL4, CXCL8, CXCL11, CXCL12, CCL2, CCL5, CCL7, CCL19, CCL21, CCL27; KD 1–85 nM) at their GAG-binding sites, and also masks cell-surface GAGs, thereby broadly inhibiting chemokine presentation on endothelial cells and impairing GAG-dependent chemokine function.","method":"Surface plasmon resonance (KD measurement), chemokine-GAG competition assays, endothelial cell chemokine presentation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative binding measurements combined with functional inhibition assays across a panel of chemokines","pmids":["27044744"],"is_preprint":false},{"year":2016,"finding":"TSG-6 inhibits TLR4-MyD88 association in macrophages, suppresses NF-κB activation, STAT1, and STAT3 activation, converts macrophages from proinflammatory to anti-inflammatory phenotype, and TSG-6-knockout mice show markedly augmented LPS-induced lung injury; LPS itself upregulates TSG-6 expression, suggesting an autocrine negative feedback loop.","method":"TSG-6−/− mice (LPS lung injury model), co-immunoprecipitation (TLR4-MyD88 association), macrophage phenotype markers, NF-κB/STAT Western blot","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — KO mouse combined with co-IP and multiple molecular pathway analyses","pmids":["27911817"],"is_preprint":false},{"year":2017,"finding":"IDO metabolite kynurenic acid (KYNA) produced by MSCs activates the aryl hydrocarbon receptor (AhR), which directly binds to the TSG-6 promoter and enhances TSG-6 expression; thus IDO controls TSG-6-mediated immunosuppression via the IDO→KYNA→AhR→TSG-6 axis.","method":"IDO deletion/inhibition in human MSCs, KYNA production inhibition, AhR activation assays, chromatin immunoprecipitation (AhR binding to TSG-6 promoter), mouse ALI model","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — ChIP demonstrating direct AhR binding to TSG-6 promoter, supported by pharmacological and genetic perturbations","pmids":["29238069"],"is_preprint":false},{"year":2011,"finding":"TSG-6 controls epithelial-mesenchymal transition (EMT) of proximal tubular epithelial cells: TGFβ1 induces TSG-6 expression and causes HA cable disassembly with formation of dense pericellular HA coats; stable knockdown of TSG-6 increases E-cadherin, prevents α-SMA induction, disrupts HA macromolecular structure, and slows cell migration, demonstrating TSG-6 is required for TGFβ1-mediated EMT via HA reorganization and CD44-dependent signaling.","method":"Stable shRNA knockdown, CD44 siRNA, TGFβ1 stimulation, immunolocalization of HA, cell migration assay, Western blot for EMT markers","journal":"International journal of biochemistry & cell biology","confidence":"High","confidence_rationale":"Tier 2 — stable knockdown with receptor (CD44) siRNA validation and multiple functional readouts","pmids":["21864707"],"is_preprint":false},{"year":2012,"finding":"TSG-6 knockdown by siRNA in fibroblasts upregulates MMP-1 and MMP-3 transcription and triggers extracellular active MMP-1 expression, demonstrating that TSG-6 normally suppresses MMP-1 transcription and prevents MMP-1 activation; this was further enhanced by IL-1β in TSG-6-deficient cells.","method":"TSG-6 siRNA knockdown in human conjunctival fibroblasts, qRT-PCR, Western blot, immunostaining of TSG-6/MMP-1/MMP-3","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — siRNA knockdown with transcriptional and protein-level readouts of MMP regulation","pmids":["22297496"],"is_preprint":false},{"year":2022,"finding":"Matrix stiffness mechanosensitively regulates TSG-6 expression in MSCs through MAPK and Hippo signaling pathways and the downstream AP1 transcription factor complex; TSG-6 produced from MSCs on soft matrices then acts on macrophages through CD44 receptor to inhibit NF-κB pathway and promote anti-inflammatory polarization.","method":"MSC culture on hydrogels of varying stiffness, MAPK/Hippo pathway inhibitors, AP1 inhibitors, CD44 receptor studies, macrophage polarization assays, subcutaneous implantation in vivo","journal":"Acta biomaterialia","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with in vitro and in vivo validation, but primarily from a single group","pmids":["35820593"],"is_preprint":false},{"year":2022,"finding":"TSG-6 in colorectal cancer cells stabilizes CD44 and facilitates CD44-EGFR complex formation on the cell membrane, activating ERK signaling and epithelial-mesenchymal transition to promote migration/invasion; secreted TSG-6 also triggers paracrine JAK2-STAT3 signaling to reprogram normal fibroblasts into cancer-associated fibroblasts that upregulate CCL5 and MMP3.","method":"TSG-6 overexpression/knockdown in CRC cells, co-immunoprecipitation (CD44-EGFR complex), ERK/STAT3 Western blot, in vitro migration/invasion assays, co-injection xenograft model","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and signaling pathway analysis with functional tumor model, single study","pmids":["35280699"],"is_preprint":false},{"year":2021,"finding":"miR-214-5p was identified as a negative regulator of TSG-6 mRNA in adipose-derived stem cells; TNFα stimulation of ADSCs upregulates TSG-6 (overriding miR-214-5p repression), and ADSC-derived TSG-6 inhibits LPS-induced proinflammatory cytokine production in BV2 microglia.","method":"High-throughput RNA sequencing, bioinformatics, microRNA-target identification, TSG-6/cytokine ELISA","journal":"BioMed research international","confidence":"Low","confidence_rationale":"Tier 3 — bioinformatics-identified miRNA with limited functional validation of the miR-214-5p → TSG-6 link","pmids":["30584538"],"is_preprint":false}],"current_model":"TNFAIP6/TSG-6 is a TNF/IL-1-inducible secreted glycoprotein (transcriptionally regulated via NF-IL6, AP-1, and AhR elements in its promoter) that functions as a multi-ligand extracellular matrix organizer and broad-spectrum anti-inflammatory mediator: its Link module binds hyaluronan (pH-dependently, maximally at pH 6.0 via stacking and ionic contacts), chondroitin sulfates, heparin, and multiple CC/CXC chemokines at their GAG-binding sites, thereby inhibiting chemokine presentation and neutrophil extravasation; its CUB module contains a Ca2+-binding site that, together with a HC2-dependent co-factor mechanism, catalyzes metal ion-dependent transesterification of heavy chains from inter-alpha-inhibitor first onto TSG-6 then onto HA to form covalent HC·HA complexes that stabilize extracellular matrices during inflammation and ovulation; full-length TSG-6 undergoes HA-induced oligomerization to cross-link HA matrices; TSG-6 signals through CD44 on macrophages and microglia to suppress TLR4/NF-κB and STAT signaling pathways; it directly inhibits RANKL-induced osteoclastogenesis and BMP-2-mediated osteoblastogenesis by binding these ligands; and its expression is upregulated in MSCs through an IDO→kynurenic acid→AhR→TSG-6 promoter axis, explaining much of the immunomodulatory paracrine activity of mesenchymal stem cells."},"narrative":{"teleology":[{"year":1993,"claim":"Establishing that TSG-6 is a primary-response gene transcriptionally activated by TNF-α and IL-1 answered the foundational question of how TSG-6 is induced during inflammation, identifying NF-IL6 and AP-1 promoter elements as the regulatory mechanism.","evidence":"Nuclear run-on, promoter deletion/reporter assays in human fibroblasts","pmids":["8454591","7876106"],"confidence":"High","gaps":["Full enhancer architecture not mapped","Post-transcriptional regulation largely unexplored at this stage"]},{"year":1997,"claim":"Demonstrating that TSG-6 forms a stable covalent complex with inter-α-inhibitor (IαI) and that its Link module binds hyaluronan and chondroitin-4-sulfate established TSG-6 as a bifunctional molecule bridging serine protease inhibition and extracellular matrix glycosaminoglycan binding.","evidence":"Biochemical complex isolation, microtiter plate binding assays with competition experiments","pmids":["9244409","9237673"],"confidence":"High","gaps":["Catalytic mechanism of HC transfer unknown","Structural basis of HA recognition unresolved"]},{"year":2000,"claim":"NMR mapping of the HA-binding groove on the Link module and ITC-measured affinities resolved which residues mediate HA recognition, revealing a mechanism based on CH-π stacking with sugar rings and ionic contacts with glucuronic acids.","evidence":"NMR chemical shift perturbation and isothermal titration calorimetry with HA oligomers","pmids":["10903951","15718240"],"confidence":"High","gaps":["pH dependence mechanism not yet molecularly defined","Role of CUB module in HA binding unknown"]},{"year":2002,"claim":"Showing that the Link module alone inhibits neutrophil migration in vivo independently of HA binding or IαI potentiation revealed a distinct anti-inflammatory mechanism separable from matrix-organizing functions.","evidence":"Site-directed mutagenesis of Link module, murine air pouch model, chimeric CD44/TSG-6 flow assays","pmids":["12401803","12011075","15513871"],"confidence":"High","gaps":["Direct molecular target on neutrophils not identified","Chemokine-binding mechanism not yet discovered"]},{"year":2004,"claim":"TSG-6 knockout mice with enhanced neutrophil infiltration and more severe arthritis provided genetic proof that endogenous TSG-6 is a non-redundant anti-inflammatory factor in vivo.","evidence":"TSG-6 KO mouse with proteoglycan-induced arthritis and thioglycollate peritonitis models","pmids":["15457471"],"confidence":"High","gaps":["Mechanism of neutrophil extravasation inhibition not fully defined","Contribution of different TSG-6 activities (HA cross-linking vs. protease inhibition) not dissected in vivo"]},{"year":2005,"claim":"Reconstitution of the two-step transesterification reaction—HC transfer from IαI chondroitin sulfate onto TSG-6, then from TSG-6 onto HA—established TSG-6 as a catalytic transferase recycled after HC·HA formation, resolving the enzymatic mechanism of covalent matrix assembly.","evidence":"In vitro reconstitution with purified IαI and recombinant TSG-6, metal ion manipulation, SDS-PAGE","pmids":["15840581","16768462"],"confidence":"High","gaps":["Active-site residues not identified","Structural basis of metal ion requirement unclear"]},{"year":2007,"claim":"Identification of His4 as the pH sensor controlling HA affinity—its deprotonation above pH 6.0 disrupts a buried salt bridge network propagating to HA-binding residue Tyr12—provided a molecular explanation for how TSG-6 activity is tuned by inflammatory acidosis.","evidence":"Site-directed mutagenesis, NMR pKa determination, ITC","pmids":["17307731"],"confidence":"High","gaps":["In vivo relevance of pH switching not directly tested","Allostery between heparin and HA sites only partially characterized"]},{"year":2007,"claim":"Crystal structure and NMR dynamics of the Link module revealed that HA-binding loops are mobile in the free state and rigidified upon HA binding, and that HA binding allosterically dampens mobility at the heparin-binding site, providing structural evidence for functional crosstalk between binding surfaces.","evidence":"X-ray crystallography and ¹⁵N NMR relaxation","pmids":["17585936"],"confidence":"High","gaps":["Full-length TSG-6 structure not determined","Structural basis of CUB-Link interplay unknown"]},{"year":2008,"claim":"Discovery that HC2 is an obligate cofactor for HC transfer from bikunin-family proteins onto HA defined a specificity checkpoint in the transesterification pathway, and demonstration that TSG-6 inhibits both RANKL-mediated osteoclastogenesis and BMP-2-mediated osteoblastogenesis expanded TSG-6's functional scope to bone remodeling.","evidence":"In vitro reconstitution with purified HC components; osteoclast/osteoblast differentiation assays and TSG-6 KO mouse bone phenotype","pmids":["18448433","18586671"],"confidence":"High","gaps":["Structural basis of RANKL/BMP-2 binding not resolved","HC2 cofactor mechanism at molecular level unknown"]},{"year":2009,"claim":"Showing that TSG-6 knockdown in MSCs abolishes cardiac repair after myocardial infarction—and that recombinant TSG-6 alone replicates the effect—identified TSG-6 as a principal paracrine effector of MSC immunotherapy.","evidence":"TSG-6 siRNA in hMSCs, recombinant TSG-6 rescue, mouse MI model","pmids":["19570514"],"confidence":"High","gaps":["Downstream signaling mechanism in cardiac tissue not defined","Relative contribution of different TSG-6 activities in cardiac protection unknown"]},{"year":2011,"claim":"TSG-6 was shown to signal through CD44 on macrophages to suppress NF-κB nuclear translocation, and full-length TSG-6 was found to oligomerize on HA and cross-link HA matrices—establishing two mechanistically distinct functions: receptor-mediated signaling and physical matrix organization.","evidence":"Zymosan peritonitis model with CD44 interaction studies; QCM-D/AFM on end-grafted HA films","pmids":["21551236","21596748"],"confidence":"High","gaps":["Oligomerization interface on TSG-6 not structurally defined","Whether CD44 signaling requires HA cross-linking not determined"]},{"year":2014,"claim":"Quantitative demonstration that TSG-6 directly binds CXCL8 and a panel of CC/CXC chemokines at nanomolar affinity via their GAG-binding sites resolved the long-standing question of how TSG-6 inhibits neutrophil extravasation: by sequestering chemokines and blocking their endothelial presentation.","evidence":"SPR binding measurements, neutrophil transendothelial migration assays, chemokine-GAG competition","pmids":["24501198","27044744"],"confidence":"High","gaps":["Relative in vivo contribution of chemokine sequestration versus other anti-inflammatory mechanisms not quantified","Selectivity determinants for different chemokines not structurally resolved"]},{"year":2015,"claim":"Crystal structure of the CUB module revealed the Ca²⁺-binding site mediating HC·TSG-6 intermediate formation and showed that HC transfer onto HA (but not HA binding) is the essential TSG-6 function for cumulus-oocyte complex expansion.","evidence":"CUB module crystal structure, transferase-impaired and HA-binding-impaired mutants in COC expansion assay","pmids":["26468290"],"confidence":"High","gaps":["No full-length TSG-6 structure","Atomic details of HC–CUB interaction unknown"]},{"year":2016,"claim":"TSG-6 was found to disrupt TLR4-MyD88 association and suppress STAT1/STAT3 signaling in macrophages, and TSG-6 KO mice showed markedly augmented LPS-induced lung injury, defining a TLR4-level signaling checkpoint and confirming an autocrine negative feedback loop.","evidence":"TSG-6 KO mouse LPS lung injury model, co-immunoprecipitation of TLR4-MyD88","pmids":["27911817"],"confidence":"High","gaps":["Direct binding site on TLR4 or MyD88 not identified","Whether TSG-6 acts on TLR4 directly or via CD44/HA intermediates not fully resolved"]},{"year":2017,"claim":"ChIP demonstrated that AhR directly binds the TSG-6 promoter downstream of IDO-generated kynurenic acid, establishing a transcriptional axis (IDO→KYNA→AhR→TSG-6) that explains how MSC immunosuppression is metabolically regulated.","evidence":"ChIP for AhR on TSG-6 promoter, IDO deletion/inhibition in MSCs, mouse ALI model","pmids":["29238069"],"confidence":"High","gaps":["Whether AhR element cooperates with NF-IL6/AP-1 elements not tested","Relevance of this axis outside MSC biology not established"]},{"year":2022,"claim":"Matrix stiffness was shown to regulate TSG-6 expression through MAPK/Hippo/AP1 signaling, and TSG-6 in colorectal cancer was found to stabilize CD44, promote CD44-EGFR complex formation, and activate ERK/STAT3 signaling—revealing that TSG-6's CD44-dependent functions can be co-opted in cancer.","evidence":"Hydrogel stiffness variation with pathway inhibitors; CRC cell TSG-6 overexpression/knockdown with co-IP and xenograft","pmids":["35820593","35280699"],"confidence":"Medium","gaps":["Cancer-associated TSG-6 functions from single studies, not independently replicated","Whether TSG-6-CD44-EGFR complex reflects a general mechanism or is cancer-specific is unclear"]},{"year":null,"claim":"No full-length TSG-6 structure exists; the atomic basis of Link-CUB module cooperation during HC transesterification, the structural determinants of TSG-6 oligomerization on HA, and the precise mechanism by which TSG-6 disrupts TLR4-MyD88 signaling remain open questions.","evidence":"","pmids":[],"confidence":"High","gaps":["Full-length structure needed to understand inter-module allostery","TSG-6 oligomerization interface not defined","Direct versus CD44/HA-mediated action on TLR4 signaling not resolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[12,16,22,33]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3,4,5,14,15,17]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,26,30,35,36]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[12,16,33]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[6,25,28,34]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[6,25,34]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,11,24,30,35,36]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[6,12,25,28,34]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[24,32,36,40,41]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[6,33]}],"complexes":["IαI·TSG-6 (HC·TSG-6 covalent intermediate)","HC·HA complex"],"partners":["ITIH1","ITIH2","CD44","THBS1","TNFSF11","BMP2","CXCL8","TLR4"],"other_free_text":[]},"mechanistic_narrative":"TNFAIP6 (TSG-6) is a TNF-α/IL-1-inducible secreted glycoprotein that functions as a broad-spectrum anti-inflammatory mediator and extracellular matrix organizer, acting through its Link and CUB modules to bind hyaluronan, multiple glycosaminoglycans, and chemokines, and to catalyze covalent heavy chain transfer onto hyaluronan. The Link module binds hyaluronan with pH-dependent affinity (maximal at pH 6.0, mediated by His4-controlled conformational switching), and also directly binds CC/CXC chemokines (CXCL8, CCL2, CCL5, and others at nanomolar affinity) at their GAG-binding sites, blocking chemokine presentation on endothelial surfaces and suppressing neutrophil extravasation [PMID:17307731, PMID:27044744, PMID:15457471]. The CUB module contains a Ca²⁺-binding site essential for metal ion-dependent transesterification that transfers inter-α-inhibitor heavy chains first onto TSG-6 then onto HA—a catalytic cycle requiring HC2 as obligate cofactor—to form covalent HC·HA matrices critical for cumulus-oocyte complex expansion and tissue remodeling [PMID:15840581, PMID:26468290, PMID:18448433]. TSG-6 additionally signals through CD44 on macrophages and microglia to suppress TLR4/NF-κB and STAT pathways, directly binds RANKL and BMP-2 to inhibit osteoclastogenesis and osteoblastogenesis, and constitutes a principal effector of MSC-mediated immunomodulation through an IDO→kynurenic acid→AhR→TSG-6 promoter axis [PMID:27911817, PMID:18586671, PMID:19570514, PMID:29238069]."},"prefetch_data":{"uniprot":{"accession":"P98066","full_name":"Tumor necrosis factor-inducible gene 6 protein","aliases":["Hyaluronate-binding protein","TNF-stimulated gene 6 protein","TSG-6","Tumor necrosis factor alpha-induced protein 6","TNF alpha-induced protein 6"],"length_aa":277,"mass_kda":31.2,"function":"Major regulator of extracellular matrix organization during tissue remodeling (PubMed:15917224, PubMed:18042364, PubMed:26823460). Catalyzes the transfer of a heavy chain (HC) from inter-alpha-inhibitor (I-alpha-I) complex to hyaluronan. Cleaves the ester bond between the C-terminus of the HC and GalNAc residue of the chondroitin sulfate chain in I-alpha-I complex followed by transesterification of the HC to hyaluronan. In the process, potentiates the antiprotease function of I-alpha-I complex through release of free bikunin (PubMed:15917224, PubMed:16873769, PubMed:20463016). Acts as a catalyst in the formation of hyaluronan-HC oligomers and hyaluronan-rich matrix surrounding the cumulus cell-oocyte complex, a necessary step for oocyte fertilization (PubMed:26468290). Assembles hyaluronan in pericellular matrices that serve as platforms for receptor clustering and signaling. Enables binding of hyaluronan deposited on the surface of macrophages to LYVE1 on lymphatic endothelium and facilitates macrophage extravasation. Alters hyaluronan binding to functionally latent CD44 on vascular endothelium, switching CD44 into an active state that supports leukocyte rolling (PubMed:15060082, PubMed:26823460). Modulates the interaction of chemokines with extracellular matrix components and proteoglycans on endothelial cell surface, likely preventing chemokine gradient formation (PubMed:27044744). In a negative feedback mechanism, may limit excessive neutrophil recruitment at inflammatory sites by antagonizing the association of CXCL8 with glycosaminoglycans on vascular endothelium (PubMed:24501198). Has a role in osteogenesis and bone remodeling. Inhibits BMP2-dependent differentiation of mesenchymal stem cell to osteoblasts (PubMed:16771708, PubMed:18586671). Protects against bone erosion during inflammation by inhibiting TNFSF11/RANKL-dependent osteoclast activation (PubMed:18586671)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P98066/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TNFAIP6","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TNFAIP6","total_profiled":1310},"omim":[{"mim_id":"605083","title":"FRIZZLED-RELATED PROTEIN; FRZB","url":"https://www.omim.org/entry/605083"},{"mim_id":"600410","title":"TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 6; TNFAIP6","url":"https://www.omim.org/entry/600410"},{"mim_id":"165720","title":"OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1","url":"https://www.omim.org/entry/165720"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"urinary bladder","ntpm":181.9}],"url":"https://www.proteinatlas.org/search/TNFAIP6"},"hgnc":{"alias_symbol":["TSG6","TSG-6"],"prev_symbol":[]},"alphafold":{"accession":"P98066","domains":[{"cath_id":"3.10.100.10","chopping":"25-129","consensus_level":"high","plddt":89.3186,"start":25,"end":129},{"cath_id":"2.60.120.290","chopping":"136-248","consensus_level":"high","plddt":94.7938,"start":136,"end":248}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P98066","model_url":"https://alphafold.ebi.ac.uk/files/AF-P98066-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P98066-F1-predicted_aligned_error_v6.png","plddt_mean":81.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TNFAIP6","jax_strain_url":"https://www.jax.org/strain/search?query=TNFAIP6"},"sequence":{"accession":"P98066","fasta_url":"https://rest.uniprot.org/uniprotkb/P98066.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P98066/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P98066"}},"corpus_meta":[{"pmid":"19570514","id":"PMC_19570514","title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.","date":"2009","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/19570514","citation_count":1493,"is_preprint":false},{"pmid":"21551236","id":"PMC_21551236","title":"Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21551236","citation_count":538,"is_preprint":false},{"pmid":"12692188","id":"PMC_12692188","title":"TSG-6: a multifunctional protein associated with inflammation.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12692188","citation_count":313,"is_preprint":false},{"pmid":"29362135","id":"PMC_29362135","title":"TSG-6: A multifunctional protein with anti-inflammatory and tissue-protective properties.","date":"2018","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29362135","citation_count":249,"is_preprint":false},{"pmid":"25790743","id":"PMC_25790743","title":"Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.","date":"2015","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/25790743","citation_count":222,"is_preprint":false},{"pmid":"23921952","id":"PMC_23921952","title":"TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds.","date":"2013","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23921952","citation_count":195,"is_preprint":false},{"pmid":"20837529","id":"PMC_20837529","title":"Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20837529","citation_count":190,"is_preprint":false},{"pmid":"16709183","id":"PMC_16709183","title":"TSG-6: a pluripotent inflammatory mediator?","date":"2006","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16709183","citation_count":182,"is_preprint":false},{"pmid":"29238069","id":"PMC_29238069","title":"Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/29238069","citation_count":165,"is_preprint":false},{"pmid":"23922312","id":"PMC_23922312","title":"Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1).","date":"2013","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/23922312","citation_count":159,"is_preprint":false},{"pmid":"27911817","id":"PMC_27911817","title":"TNFα-stimulated gene-6 (TSG6) activates macrophage phenotype transition to prevent inflammatory lung injury.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27911817","citation_count":158,"is_preprint":false},{"pmid":"9244409","id":"PMC_9244409","title":"TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity.","date":"1997","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/9244409","citation_count":151,"is_preprint":false},{"pmid":"15840581","id":"PMC_15840581","title":"Characterization of complexes formed between TSG-6 and inter-alpha-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15840581","citation_count":151,"is_preprint":false},{"pmid":"15060082","id":"PMC_15060082","title":"TSG-6 modulates the interaction between hyaluronan and cell surface CD44.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15060082","citation_count":151,"is_preprint":false},{"pmid":"29941022","id":"PMC_29941022","title":"Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.","date":"2018","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29941022","citation_count":150,"is_preprint":false},{"pmid":"24501198","id":"PMC_24501198","title":"TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24501198","citation_count":148,"is_preprint":false},{"pmid":"8245487","id":"PMC_8245487","title":"TSG-6: a TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8245487","citation_count":135,"is_preprint":false},{"pmid":"34051868","id":"PMC_34051868","title":"A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6.","date":"2021","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34051868","citation_count":132,"is_preprint":false},{"pmid":"23349496","id":"PMC_23349496","title":"TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/23349496","citation_count":125,"is_preprint":false},{"pmid":"21596748","id":"PMC_21596748","title":"The inflammation-associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21596748","citation_count":116,"is_preprint":false},{"pmid":"12401803","id":"PMC_12401803","title":"The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12401803","citation_count":106,"is_preprint":false},{"pmid":"25088370","id":"PMC_25088370","title":"Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.","date":"2014","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/25088370","citation_count":99,"is_preprint":false},{"pmid":"25890011","id":"PMC_25890011","title":"The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6.","date":"2015","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/25890011","citation_count":96,"is_preprint":false},{"pmid":"30126439","id":"PMC_30126439","title":"TSG-6 attenuates inflammation-induced brain injury via modulation of microglial polarization in SAH rats through the SOCS3/STAT3 pathway.","date":"2018","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/30126439","citation_count":94,"is_preprint":false},{"pmid":"22912904","id":"PMC_22912904","title":"Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22912904","citation_count":90,"is_preprint":false},{"pmid":"27044744","id":"PMC_27044744","title":"The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27044744","citation_count":88,"is_preprint":false},{"pmid":"23851308","id":"PMC_23851308","title":"Administration of TSG-6 improves memory after traumatic brain injury in mice.","date":"2013","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/23851308","citation_count":85,"is_preprint":false},{"pmid":"11420253","id":"PMC_11420253","title":"TSG-6 is concentrated in the extracellular matrix of mouse cumulus oocyte complexes through hyaluronan and inter-alpha-inhibitor binding.","date":"2001","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11420253","citation_count":84,"is_preprint":false},{"pmid":"19389798","id":"PMC_19389798","title":"Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6.","date":"2009","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/19389798","citation_count":79,"is_preprint":false},{"pmid":"10903951","id":"PMC_10903951","title":"Localization and characterization of the hyaluronan-binding site on the link module from human TSG-6.","date":"2000","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/10903951","citation_count":78,"is_preprint":false},{"pmid":"29301108","id":"PMC_29301108","title":"Mesenchymal Stromal Cells Inhibit Inflammatory Lymphangiogenesis in the Cornea by Suppressing Macrophage in a TSG-6-Dependent Manner.","date":"2017","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29301108","citation_count":78,"is_preprint":false},{"pmid":"15457471","id":"PMC_15457471","title":"Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice.","date":"2004","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/15457471","citation_count":76,"is_preprint":false},{"pmid":"32800897","id":"PMC_32800897","title":"Exosomes derived from TSG-6 modified mesenchymal stromal cells attenuate scar formation during wound healing.","date":"2020","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/32800897","citation_count":69,"is_preprint":false},{"pmid":"35690131","id":"PMC_35690131","title":"Exosomes from LPS-preconditioned bone marrow MSCs accelerated peripheral nerve regeneration via M2 macrophage polarization: Involvement of TSG-6/NF-κB/NLRP3 signaling pathway.","date":"2022","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35690131","citation_count":69,"is_preprint":false},{"pmid":"9237673","id":"PMC_9237673","title":"Overlapping sites on the Link module of human TSG-6 mediate binding to hyaluronan and chrondroitin-4-sulphate.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9237673","citation_count":68,"is_preprint":false},{"pmid":"15718240","id":"PMC_15718240","title":"Towards a structure for a TSG-6.hyaluronan complex by modeling and NMR spectroscopy: insights into other members of the link module superfamily.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15718240","citation_count":67,"is_preprint":false},{"pmid":"12011075","id":"PMC_12011075","title":"Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12011075","citation_count":65,"is_preprint":false},{"pmid":"12355494","id":"PMC_12355494","title":"Reduced susceptibility to collagen-induced arthritis in DBA/1J mice expressing the TSG-6 transgene.","date":"2002","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/12355494","citation_count":64,"is_preprint":false},{"pmid":"24005673","id":"PMC_24005673","title":"Inter-α-inhibitor impairs TSG-6-induced hyaluronan cross-linking.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24005673","citation_count":63,"is_preprint":false},{"pmid":"31903104","id":"PMC_31903104","title":"Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31903104","citation_count":62,"is_preprint":false},{"pmid":"11145024","id":"PMC_11145024","title":"Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.","date":"2000","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/11145024","citation_count":62,"is_preprint":false},{"pmid":"24979372","id":"PMC_24979372","title":"Therapeutic effect of TSG-6 engineered iPSC-derived MSCs on experimental periodontitis in rats: a pilot study.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24979372","citation_count":61,"is_preprint":false},{"pmid":"9654129","id":"PMC_9654129","title":"TSG-6 interacts with hyaluronan and aggrecan in a pH-dependent manner via a common functional element: implications for its regulation in inflamed cartilage.","date":"1998","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9654129","citation_count":59,"is_preprint":false},{"pmid":"25014173","id":"PMC_25014173","title":"MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25014173","citation_count":56,"is_preprint":false},{"pmid":"24242012","id":"PMC_24242012","title":"Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs.","date":"2013","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24242012","citation_count":53,"is_preprint":false},{"pmid":"8454591","id":"PMC_8454591","title":"Transcriptional regulation of TSG6, a tumor necrosis factor- and interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8454591","citation_count":53,"is_preprint":false},{"pmid":"26468290","id":"PMC_26468290","title":"Metal Ion-dependent Heavy Chain Transfer Activity of TSG-6 Mediates Assembly of the Cumulus-Oocyte Matrix.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26468290","citation_count":49,"is_preprint":false},{"pmid":"33422134","id":"PMC_33422134","title":"Inflammatory cytokines-stimulated human muscle stem cells ameliorate ulcerative colitis via the IDO-TSG6 axis.","date":"2021","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33422134","citation_count":48,"is_preprint":false},{"pmid":"18586671","id":"PMC_18586671","title":"TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18586671","citation_count":47,"is_preprint":false},{"pmid":"15513871","id":"PMC_15513871","title":"Inhibitory effects of TSG-6 Link module on leukocyte-endothelial cell interactions in vitro and in vivo.","date":"2004","source":"Microcirculation (New York, N.Y. : 1994)","url":"https://pubmed.ncbi.nlm.nih.gov/15513871","citation_count":46,"is_preprint":false},{"pmid":"31472111","id":"PMC_31472111","title":"Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6.","date":"2019","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/31472111","citation_count":45,"is_preprint":false},{"pmid":"29483622","id":"PMC_29483622","title":"TSG-6 secreted by bone marrow mesenchymal stem cells attenuates intervertebral disc degeneration by inhibiting the TLR2/NF-κB signaling pathway.","date":"2018","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29483622","citation_count":45,"is_preprint":false},{"pmid":"21162099","id":"PMC_21162099","title":"TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin.","date":"2011","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21162099","citation_count":44,"is_preprint":false},{"pmid":"23129777","id":"PMC_23129777","title":"Tumor necrosis factor-stimulated gene-6 (TSG-6) amplifies hyaluronan synthesis by airway smooth muscle cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23129777","citation_count":44,"is_preprint":false},{"pmid":"24403066","id":"PMC_24403066","title":"A refined model for the TSG-6 link module in complex with hyaluronan: use of defined oligosaccharides to probe structure and function.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24403066","citation_count":43,"is_preprint":false},{"pmid":"19383344","id":"PMC_19383344","title":"TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles.","date":"2008","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19383344","citation_count":42,"is_preprint":false},{"pmid":"8630102","id":"PMC_8630102","title":"TSG-6 expression in human articular chondrocytes. Possible implications in joint inflammation and cartilage degradation.","date":"1996","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/8630102","citation_count":42,"is_preprint":false},{"pmid":"30507579","id":"PMC_30507579","title":"Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimer's Disease.","date":"2019","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/30507579","citation_count":41,"is_preprint":false},{"pmid":"29129649","id":"PMC_29129649","title":"TSG-6 - a double-edged sword for osteoarthritis (OA).","date":"2017","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/29129649","citation_count":41,"is_preprint":false},{"pmid":"36433947","id":"PMC_36433947","title":"Mesenchymal stem/stromal cells primed by inflammatory cytokines alleviate psoriasis-like inflammation via the TSG-6-neutrophil axis.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36433947","citation_count":37,"is_preprint":false},{"pmid":"26244293","id":"PMC_26244293","title":"Topical TSG-6 Administration Protects the Ocular Surface in Two Mouse Models of Inflammation-Related Dry Eye.","date":"2015","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/26244293","citation_count":37,"is_preprint":false},{"pmid":"28963485","id":"PMC_28963485","title":"Human Amniotic Membrane Mesenchymal Stem Cells inhibit Neutrophil Extracellular Traps through TSG-6.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28963485","citation_count":37,"is_preprint":false},{"pmid":"15699048","id":"PMC_15699048","title":"TSG-6 protein binding to glycosaminoglycans: formation of stable complexes with hyaluronan and binding to chondroitin sulfates.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15699048","citation_count":36,"is_preprint":false},{"pmid":"33670243","id":"PMC_33670243","title":"HGF and TSG-6 Released by Mesenchymal Stem Cells Attenuate Colon Radiation-Induced Fibrosis.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33670243","citation_count":35,"is_preprint":false},{"pmid":"16006654","id":"PMC_16006654","title":"The N-terminal module of thrombospondin-1 interacts with the link domain of TSG-6 and enhances its covalent association with the heavy chains of inter-alpha-trypsin inhibitor.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16006654","citation_count":35,"is_preprint":false},{"pmid":"38588501","id":"PMC_38588501","title":"TSG6-Exo@CS/GP Attenuates Endometrium Fibrosis by Inhibiting Macrophage Activation in a Murine IUA Model.","date":"2024","source":"Advanced materials (Deerfield Beach, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/38588501","citation_count":34,"is_preprint":false},{"pmid":"26807900","id":"PMC_26807900","title":"Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.","date":"2016","source":"Cornea","url":"https://pubmed.ncbi.nlm.nih.gov/26807900","citation_count":34,"is_preprint":false},{"pmid":"29564448","id":"PMC_29564448","title":"Intra-articular TSG-6 delivery from heparin-based microparticles reduces cartilage damage in a rat model of osteoarthritis.","date":"2018","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/29564448","citation_count":34,"is_preprint":false},{"pmid":"25661977","id":"PMC_25661977","title":"Anti-inflammatory cytokine TSG-6 inhibits hypertrophic scar formation in a rabbit ear model.","date":"2015","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25661977","citation_count":34,"is_preprint":false},{"pmid":"24983309","id":"PMC_24983309","title":"Adipose tissue-derived stem cells suppress acute cellular rejection by TSG-6 and CD44 interaction in rat kidney transplantation.","date":"2014","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/24983309","citation_count":34,"is_preprint":false},{"pmid":"34112260","id":"PMC_34112260","title":"Placental chorionic plate-derived mesenchymal stem cells ameliorate severe acute pancreatitis by regulating macrophage polarization via secreting TSG-6.","date":"2021","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34112260","citation_count":34,"is_preprint":false},{"pmid":"18448433","id":"PMC_18448433","title":"The transfer of heavy chains from bikunin proteins to hyaluronan requires both TSG-6 and HC2.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18448433","citation_count":33,"is_preprint":false},{"pmid":"22452753","id":"PMC_22452753","title":"Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model.","date":"2012","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22452753","citation_count":32,"is_preprint":false},{"pmid":"33554782","id":"PMC_33554782","title":"Mesenchymal stem cells protect renal tubular cells via TSG-6 regulating macrophage function and phenotype switching.","date":"2021","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33554782","citation_count":30,"is_preprint":false},{"pmid":"35280699","id":"PMC_35280699","title":"TSG-6 promotes Cancer Cell aggressiveness in a CD44-Dependent Manner and Reprograms Normal Fibroblasts to create a Pro-metastatic Microenvironment in Colorectal Cancer.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35280699","citation_count":29,"is_preprint":false},{"pmid":"35820593","id":"PMC_35820593","title":"Matrix stiffness regulates the immunomodulatory effects of mesenchymal stem cells on macrophages via AP1/TSG-6 signaling pathways.","date":"2022","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/35820593","citation_count":28,"is_preprint":false},{"pmid":"9126602","id":"PMC_9126602","title":"Method for quantitative refolding of the link module from human TSG-6.","date":"1997","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/9126602","citation_count":28,"is_preprint":false},{"pmid":"34305453","id":"PMC_34305453","title":"BMSCs Regulate Astrocytes through TSG-6 to Protect the Blood-Brain Barrier after Subarachnoid Hemorrhage.","date":"2021","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/34305453","citation_count":26,"is_preprint":false},{"pmid":"17307731","id":"PMC_17307731","title":"Determining the molecular basis for the pH-dependent interaction between the link module of human TSG-6 and hyaluronan.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17307731","citation_count":26,"is_preprint":false},{"pmid":"18806261","id":"PMC_18806261","title":"Hyaluronan binding to link module of TSG-6 and to G1 domain of aggrecan is differently regulated by pH.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18806261","citation_count":25,"is_preprint":false},{"pmid":"16768462","id":"PMC_16768462","title":"Evidence for a two-step mechanism involved in the formation of covalent HC x TSG-6 complexes.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16768462","citation_count":25,"is_preprint":false},{"pmid":"25329668","id":"PMC_25329668","title":"Human adipose-derived stem cells ameliorate cigarette smoke-induced murine myelosuppression via secretion of TSG-6.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/25329668","citation_count":25,"is_preprint":false},{"pmid":"35982465","id":"PMC_35982465","title":"Mesenchymal stem cells protect against TBI-induced pyroptosis in vivo and in vitro through TSG-6.","date":"2022","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/35982465","citation_count":24,"is_preprint":false},{"pmid":"32942629","id":"PMC_32942629","title":"Potential of Extracellular Vesicle-Associated TSG-6 from Adipose Mesenchymal Stromal Cells in Traumatic Brain Injury.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32942629","citation_count":24,"is_preprint":false},{"pmid":"25325979","id":"PMC_25325979","title":"Analysis of the heavy-chain modification and TSG-6 activity in pathological hyaluronan matrices.","date":"2015","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/25325979","citation_count":24,"is_preprint":false},{"pmid":"26178374","id":"PMC_26178374","title":"Acute and temporal expression of tumor necrosis factor (TNF)-α-stimulated gene 6 product, TSG6, in mesenchymal stem cells creates microenvironments required for their successful transplantation into muscle tissue.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26178374","citation_count":22,"is_preprint":false},{"pmid":"17585936","id":"PMC_17585936","title":"Plasticity of the TSG-6 HA-binding loop and mobility in the TSG-6-HA complex revealed by NMR and X-ray crystallography.","date":"2007","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17585936","citation_count":22,"is_preprint":false},{"pmid":"30584538","id":"PMC_30584538","title":"Upregulated TSG-6 Expression in ADSCs Inhibits the BV2 Microglia-Mediated Inflammatory Response.","date":"2018","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/30584538","citation_count":21,"is_preprint":false},{"pmid":"31931878","id":"PMC_31931878","title":"Mesenchymal stem cells alleviate liver injury induced by chronic-binge ethanol feeding in mice via release of TSG6 and suppression of STAT3 activation.","date":"2020","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31931878","citation_count":21,"is_preprint":false},{"pmid":"27088253","id":"PMC_27088253","title":"TNFAIP6 is a potential biomarker of disease activity in inflammatory bowel disease.","date":"2016","source":"Biomarkers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27088253","citation_count":20,"is_preprint":false},{"pmid":"26793973","id":"PMC_26793973","title":"Scalable Production of a Multifunctional Protein (TSG-6) That Aggregates with Itself and the CHO Cells That Synthesize It.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26793973","citation_count":20,"is_preprint":false},{"pmid":"34416923","id":"PMC_34416923","title":"Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation.","date":"2021","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34416923","citation_count":19,"is_preprint":false},{"pmid":"32116692","id":"PMC_32116692","title":"TSG-6 Inhibits Oxidative Stress and Induces M2 Polarization of Hepatic Macrophages in Mice With Alcoholic Hepatitis via Suppression of STAT3 Activation.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32116692","citation_count":19,"is_preprint":false},{"pmid":"27043548","id":"PMC_27043548","title":"Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27043548","citation_count":19,"is_preprint":false},{"pmid":"36153571","id":"PMC_36153571","title":"TNFAIP6 defines the MSC subpopulation with enhanced immune suppression activities.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36153571","citation_count":19,"is_preprint":false},{"pmid":"35222649","id":"PMC_35222649","title":"Human Umbilical Cord-Derived Mesenchymal Stem Cells Alleviate Acute Lung Injury Caused by Severe Burn via Secreting TSG-6 and Inhibiting Inflammatory Response.","date":"2022","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/35222649","citation_count":18,"is_preprint":false},{"pmid":"22297496","id":"PMC_22297496","title":"TSG-6 controls transcription and activation of matrix metalloproteinase 1 in conjunctivochalasis.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22297496","citation_count":17,"is_preprint":false},{"pmid":"26149224","id":"PMC_26149224","title":"Intravitreal TSG-6 suppresses laser-induced choroidal neovascularization by inhibiting CCR2+ monocyte recruitment.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26149224","citation_count":17,"is_preprint":false},{"pmid":"7876106","id":"PMC_7876106","title":"Activation of the TSG-6 gene by NF-IL6 requires two adjacent NF-IL6 binding sites.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7876106","citation_count":17,"is_preprint":false},{"pmid":"21864707","id":"PMC_21864707","title":"Tumour necrosis factor-stimulated gene (TSG)-6 controls epithelial-mesenchymal transition of proximal tubular epithelial cells.","date":"2011","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21864707","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54832,"output_tokens":10303,"usd":0.159521},"stage2":{"model":"claude-opus-4-6","input_tokens":14481,"output_tokens":4120,"usd":0.263107},"total_usd":0.422628,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"TSG-6 gene is transcriptionally activated by TNF-α and IL-1 as a primary response gene in human fibroblasts; the TSG-6 gene was mapped to human chromosome 2 and its promoter region contains NF-IL6, AP-1, and IRF binding sites that mediate cytokine-induced transcription. Deletion analysis showed a region from -165 to -58 bp confers IL-1/TNF inducibility.\",\n      \"method\": \"Nuclear run-on transcription assay, Southern blot, primer extension, deletion analysis with CAT reporter gene transfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods in a single rigorous study defining promoter elements\",\n      \"pmids\": [\"8454591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Activation of the TSG-6 promoter by NF-IL6 requires two functionally interdependent adjacent NF-IL6 binding sites (at positions -106 to -114 and -92 to -83); mutation of either site greatly decreased or abolished NF-IL6-driven transcription.\",\n      \"method\": \"Footprinting, EMSA, site-directed mutagenesis, reporter gene (CAT) transfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with EMSA and functional reporter assay\",\n      \"pmids\": [\"7876106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"TSG-6 forms a stable covalent complex (~120 kDa) with the serum protease inhibitor inter-alpha-inhibitor (IαI) and potentiates IαI's anti-plasmin activity, constituting a mechanism for TSG-6's anti-inflammatory effects via modulation of the protease network.\",\n      \"method\": \"Biochemical complex isolation, anti-plasmin activity assay, SDS-PAGE\",\n      \"journal\": \"Cytokine & growth factor reviews\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — biochemical characterization in a review but summarizing direct experimental data; replicated in subsequent studies\",\n      \"pmids\": [\"9244409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The Link module of TSG-6 binds hyaluronan and chondroitin-4-sulphate at overlapping sites, but does not bind chondroitin-6-sulphate or heparin; this was determined by microtiter plate-based binding assays and competition experiments.\",\n      \"method\": \"Microtiter plate binding assay with biotinylated hyaluronan and biotinylated Link module, competition experiments\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct binding assay with competition experiments establishing ligand specificity\",\n      \"pmids\": [\"9237673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TSG-6 binds hyaluronan and aggrecan through a common binding surface in a pH-dependent manner, with maximal binding at pH 6.0 and dramatic loss of function at higher pH, suggesting TSG-6 activity is regulated by pH gradients in inflamed cartilage.\",\n      \"method\": \"Microtiter plate binding assays at different pH values, competition experiments with hyaluronan\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro binding assays with mechanistic interpretation\",\n      \"pmids\": [\"9654129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The HA-binding site on the Link module of TSG-6 was localized by NMR spectroscopy to residues Lys11, Tyr59, Asn67, Phe70, Lys72, and Tyr78, and isothermal titration calorimetry showed that a single Link module is sufficient for high-affinity HA binding (KD ~0.2–0.5 μM for HA oligomers ≥6-mers).\",\n      \"method\": \"NMR spectroscopy (chemical shift perturbation), isothermal titration calorimetry\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-based mapping with calorimetric validation\",\n      \"pmids\": [\"10903951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TSG-6 co-localizes with IαI and hyaluronan in the cumulus-oocyte complex extracellular matrix, and Western blot confirmed the presence of both free TSG-6 and TSG-6/IαI complexes in ovulated COCs, suggesting TSG-6 has a structural role in COC matrix formation possibly by cross-linking HA molecules via IαI.\",\n      \"method\": \"Immunofluorescence, laser confocal microscopy, Western blot\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with protein complex detection, consistent with functional context\",\n      \"pmids\": [\"11420253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The isolated recombinant Link module of TSG-6 (Link_TSG6) inhibits neutrophil migration in vivo equivalently to full-length protein in an HA-binding and IαI-complex-independent manner; mutagenesis of six residues showed this anti-inflammatory activity is entirely within the Link module but is not dependent on HA binding or potentiation of IαI anti-plasmin activity.\",\n      \"method\": \"In vivo murine air pouch model, in vitro anti-plasmin assay, site-directed mutagenesis of Link module, recombinant protein production in Drosophila expression system\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with in vivo and in vitro functional assays\",\n      \"pmids\": [\"12401803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Replacement of the CD44 Link module with the TSG-6 Link module (higher HA affinity) converted rolling leukocyte behavior to firm tethering under flow, demonstrating that the low intrinsic HA affinity of CD44's Link module (relative to TSG-6's) is mechanistically important for leukocyte rolling.\",\n      \"method\": \"CD44/TSG-6 chimera expression in cells, parallel plate flow assay, hyaluronan binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in chimeric protein with functional flow assay\",\n      \"pmids\": [\"12011075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TSG-6 preincubation with hyaluronan enhances or induces CD44-mediated HA binding on lymphoid cells; this is mediated through the Link module's HA-binding function and may involve TSG-6-mediated HA cross-linking that promotes receptor clustering and increases binding avidity.\",\n      \"method\": \"Cell binding assays, CD44-blocking antibodies, CD44-negative cell controls, flow assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal functional experiments with blocking antibodies and CD44-negative controls\",\n      \"pmids\": [\"15060082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TSG-6-knockout mice show enhanced neutrophil extravasation, elevated plasmin/myeloperoxidase/neutrophil elastase activities in inflamed joints, and more severe proteoglycan-induced arthritis, demonstrating that endogenous TSG-6 inhibits neutrophil extravasation and protease activity at inflammatory sites.\",\n      \"method\": \"TSG-6 knockout mouse, proteoglycan-induced arthritis model, thioglycollate peritonitis model, enzyme activity assays\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple disease models and molecular readouts, replicated with recombinant protein rescue\",\n      \"pmids\": [\"15457471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The TSG-6 Link module inhibits leukocyte rolling, adhesion, and emigration in IL-1β–inflamed mesenteries in vivo, and inhibits neutrophil transmigration across endothelial monolayers in vitro, without affecting neutrophil chemotaxis or endothelial cell activation directly.\",\n      \"method\": \"Intravital microscopy of mouse mesentery, in vitro neutrophil transmigration assay\",\n      \"journal\": \"Microcirculation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro assays with mechanistic dissection\",\n      \"pmids\": [\"15513871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TSG-6 acts as a cofactor and catalyst (transferase) for the formation of heavy chain-HA (HC·HA) complexes: it forms covalent HC·TSG-6 intermediates (TSG-6·HC1 and TSG-6·HC2) via transesterification from IαI chondroitin sulfate, then transfers HCs onto HA in a second metal ion-dependent (Mg2+ or Mn2+; inhibited by Co2+) transesterification; TSG-6 is then recycled.\",\n      \"method\": \"In vitro reconstitution with purified IαI and recombinant TSG-6, SDS-PAGE, metal ion substitution/chelation experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with purified components, mechanistic dissection of reaction steps\",\n      \"pmids\": [\"15840581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The N-terminal module of thrombospondin-1 (TSP1) binds directly to the Link module of TSG-6 (KD comparable to TSG-6's GAG interactions); heparin (bound to TSP1) inhibits the interaction. TSP1 enhances covalent HC·TSG-6 formation and subsequent HC transfer onto HA.\",\n      \"method\": \"Radioligand binding assay (125I-TSP1), recombinant domain mapping, heparin/hyaluronan competition, in vitro HC transfer assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct binding assay with multiple recombinant domains and functional HC transfer reconstitution\",\n      \"pmids\": [\"16006654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Full-length TSG-6 binds hyaluronan to form a stable, dissociation-resistant complex in a temperature-dependent manner; TSG-6 also binds all chondroitin sulfate isoforms under physiological conditions. TSG-6 binding to immobilized HA does not block subsequent lymphoid cell adhesion to HA.\",\n      \"method\": \"Protein-HA binding assay with dissociating agents, temperature dependence, cell adhesion assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical binding assays with multiple glycosaminoglycans\",\n      \"pmids\": [\"15699048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NMR spectroscopy combined with molecular modeling defined the HA-binding groove of the TSG-6 Link module in detail: two adjacent tyrosine residues form CH-π stacking interactions with HA sugar rings, acetamido groups of GlcNAc fit into hydrophobic pockets providing HA selectivity over other polysaccharides, and two basic residues form salt bridges with glucuronic acids.\",\n      \"method\": \"NMR spectroscopy with 13C/15N-labeled HA, molecular docking, sequence alignment/homology modeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with mechanistic validation\",\n      \"pmids\": [\"15718240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Two-step mechanism for HC·TSG-6 complex formation: (1) a cation-independent non-covalent interaction between TSG-6 and the chondroitin sulfate chain of IαI (KD ~180 nM at site 1); (2) a cation-dependent (Mn2+, Mg2+, or Ca2+) transesterification generating the covalent HC·TSG-6 cross-link at a distinct site 2; intact native folds of both IαI and TSG-6 and an intact chondroitin sulfate chain are required.\",\n      \"method\": \"In vitro reconstitution with purified proteins, divalent cation manipulation, limited proteolysis, chondroitin sulfate cleavage\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with mechanistic dissection of two-step reaction\",\n      \"pmids\": [\"16768462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Heparin binding to TSG-6's Link module inhibits subsequent HA binding even though heparin binds a distinct site from HA, revealing allosteric communication between the heparin-binding and HA-binding sites; pH also modulates binding to HA, heparin, and protein ligands, suggesting differential partitioning of TSG-6 function in different tissue microenvironments.\",\n      \"method\": \"Binding competition assays, pH variation studies, glycosaminoglycan specificity profiling\",\n      \"journal\": \"Biochemical Society transactions\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional binding studies with mechanistic interpretation; confirmed by subsequent NMR work\",\n      \"pmids\": [\"16709183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The pH-dependent interaction of TSG-6 with HA is mechanistically mediated by His4: upon deprotonation above pH 6.0, His4 disrupts a salt bridge with buried Asp89, which is simultaneously hydrogen-bonded to key HA-binding residue Tyr12, thereby reducing HA affinity. His45 is responsible for affinity gain between pH 3.5 and 6.0.\",\n      \"method\": \"Site-directed mutagenesis, NMR (pKa determination, folding profiles), isothermal titration calorimetry, microtiter plate assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with NMR and ITC, defining a molecular mechanism\",\n      \"pmids\": [\"17307731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"X-ray crystallography and 15N NMR relaxation of the TSG-6 Link module revealed high mobility in the β4/β5 loop and at the Cys47-Cys68 disulfide bond (both HA-binding regions) in the free protein; HA binding dampens this mobility. Lys54 (heparin-binding site) becomes less mobile when HA is bound, providing evidence for allostery between the HA and heparin-binding sites.\",\n      \"method\": \"X-ray crystallography, 15N NMR relaxation, heparin docking calculations\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with NMR dynamics and mutagenesis-informed docking\",\n      \"pmids\": [\"17585936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TSG-6 inhibits RANKL-induced osteoclast differentiation/activation and BMP-2-mediated osteoblast differentiation via direct binding to RANKL and BMP-2 (but not BMP-3) through composite surfaces involving both its Link and CUB modules; TSG-6-knockout mice have elevated trabecular bone mass in unchallenged conditions.\",\n      \"method\": \"In vitro osteoclast and osteoblast differentiation assays, direct protein-protein binding (interaction analysis), TSG-6 KO mouse bone phenotype\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct binding combined with KO mouse phenotype and domain mapping\",\n      \"pmids\": [\"18586671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Confocal FRAP demonstrated that the TSG-6 Link module binds polymeric HA with maximal affinity at pH 6.0 (100-fold higher affinity than at pH 7.4), while aggrecan G1 has maximal binding at pH 7.0–8.0, explaining their differential roles in normal versus inflamed cartilage.\",\n      \"method\": \"Confocal fluorescence recovery after photobleaching (FRAP) with labeled proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative biophysical method defining affinity and pH dependence\",\n      \"pmids\": [\"18806261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HC transfer from bikunin proteins to HA requires both TSG-6 and HC2: HC2 (from IαI, HC2.bikunin, or free HC2) promotes formation of HC3·TSG-6 and subsequently HC3·HA complexes; HC1 or HC3 alone cannot perform this role.\",\n      \"method\": \"In vitro reconstitution with purified components from human plasma, SDS-PAGE identification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with biochemical identification of the required co-factor\",\n      \"pmids\": [\"18448433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Intravenously infused human MSCs become trapped as emboli in the lung and are activated to upregulate TSG-6 expression; TSG-6 knockdown (siRNA) in hMSCs abolishes the reduction of infarct size and inflammatory responses after myocardial infarction, and recombinant TSG-6 alone replicates the therapeutic effect.\",\n      \"method\": \"Quantitative human DNA/mRNA tracking in tissues, TSG-6 siRNA knockdown in hMSCs, recombinant TSG-6 administration, mouse myocardial infarction model\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown plus recombinant protein rescue in a disease model, replicated across multiple experimental arms\",\n      \"pmids\": [\"19570514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TSG-6 interacts with CD44 on resident peritoneal macrophages to decrease zymosan/TLR2-mediated nuclear translocation of NF-κB, establishing a CD44-dependent mechanism by which TSG-6 reduces macrophage-driven inflammation.\",\n      \"method\": \"Zymosan-induced peritonitis model, NF-κB nuclear translocation assay, CD44 interaction studies\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway (TSG-6 → CD44 → TLR2/NF-κB) defined in vivo and in vitro\",\n      \"pmids\": [\"21551236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Full-length TSG-6 cross-links HA via HA-induced TSG-6 oligomerization (positive cooperative binding); the TSG-6 oligomers act as cross-linkers that condense and rigidify HA films. The isolated Link module alone binds HA without cooperativity and with lower affinity and cannot cross-link HA.\",\n      \"method\": \"End-grafted HA films, quartz crystal microbalance, surface-sensitive biophysical techniques (QCM-D, reflectometry), atomic force microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted biophysical system with multiple orthogonal surface techniques establishing cooperativity and cross-linking\",\n      \"pmids\": [\"21596748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TSG-6 inhibits RANKL-mediated osteoclast activation via an autocrine mechanism: osteoclast precursors and mature osteoclasts produce TSG-6 in response to TNFα, IL-1, and IL-6, and anti-TSG-6 antibody increases lacunar resorption. TSG-6 acts synergistically with osteoprotegerin.\",\n      \"method\": \"Osteoclast differentiation/resorption assays, anti-TSG-6 neutralizing antibody, ELISA for TSG-6 in conditioned media and synovial fluid\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — antibody neutralization of endogenously produced TSG-6 with functional readout, combined with protein quantification\",\n      \"pmids\": [\"21162099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TSG-6 amplifies hyaluronan synthesis by airway smooth muscle cells: when added together with poly(I:C), TSG-6 increases HA accumulation in the cell-associated matrix and induces HA synthesis, an effect absent with TSG-6 alone. This occurs via a mechanism independent of TSG-6, HAS1/3, or CD44 on the smooth muscle cells themselves.\",\n      \"method\": \"Airway smooth muscle cell cultures from TSG-6−/−, HAS1/3−/−, and CD44−/− mice, HA accumulation assays, poly(I:C) stimulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple knockout cell lines used to dissect mechanism\",\n      \"pmids\": [\"23129777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IαI impairs TSG-6-induced HA cross-linking: in the presence of IαI, TSG-6-mediated cross-linking and condensation of HA films is suppressed, and this suppresses TSG-6-mediated enhancement of HA binding to CD44-positive cells. Two types of TSG-6/IαI complexes form on HA: covalent HC·TSG-6 (weakly bound to HA) and a novel noncovalent HA-stable complex.\",\n      \"method\": \"End-grafted HA films, surface-sensitive biophysics (QCM-D, reflectometry), CD44-positive cell binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted biophysical system revealing regulatory interplay between IαI and TSG-6 functions\",\n      \"pmids\": [\"24005673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Assembly of MSCs into spheres activates caspase-dependent IL-1α/β signaling, which drives upregulation of TSG-6, STC1, and COX2/PGE2. Inhibitors of caspases reduce IL-1A/B expression; inhibitors of IL-1 signaling decrease TSG-6 and PGE2 production and negate anti-inflammatory effects on macrophages.\",\n      \"method\": \"Hanging drop sphere cultures, caspase inhibitors, IL-1 signaling inhibitors, Notch inhibitors (γ-secretase), gene expression profiling\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with multiple inhibitors and functional readout\",\n      \"pmids\": [\"23922312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TSG-6 directly binds CXCL8 (KD ~25 nM) at the CXCL8 glycosaminoglycan-binding site via the TSG-6 Link module, antagonizing CXCL8-heparin association, impairing CXCL8 binding to cell-surface glycosaminoglycans, blocking CXCL8 transcytosis across endothelial monolayers, and suppressing CXCL8-stimulated neutrophil transendothelial migration.\",\n      \"method\": \"SPR/binding affinity measurement, neutrophil transendothelial migration assay, CXCL8-heparin competition assay, CXCL8 cell-surface binding assay, transcytosis assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct binding with KD measurement plus multiple functional assays\",\n      \"pmids\": [\"24501198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TSG-6 refined NMR-based model of the Link module-HA complex: HA makes more extensive contacts than previously thought; a glucuronic acid ring makes stacking and ionic interactions with a histidine and lysine, causing HA to bend around two faces of the Link module in a manner resembling CD44-HA interaction. The HA-binding site is NOT used for recognition during HC transfer onto HA.\",\n      \"method\": \"NMR spectroscopy with 10 distinct HA oligosaccharides (4- to 8-mers), 13C-labeled octasaccharide, chondroitin/HA hybrid oligomers, TSG-6 mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural study with novel reagents and functional mutant validation\",\n      \"pmids\": [\"24403066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TSG-6 inhibits LPS-induced NF-κB and MAPK pathway activation in BV2 microglial cells in a CD44-dependent manner; knockdown of CD44 in BV2 cells abrogated TSG-6-mediated inhibition of pro-inflammatory gene expression and NF-κB/MAPK activation.\",\n      \"method\": \"LPS-stimulated BV2 microglial cell culture, TSG-6 treatment, CD44 siRNA knockdown, NF-κB/MAPK pathway analysis by Western blot\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pathway mechanistic dissection with receptor knockdown\",\n      \"pmids\": [\"25088370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The TSG-6 CUB module structure was determined, revealing a calcium ion-binding site with a chelating glutamic acid residue that mediates formation of HC·TSG-6 intermediates via an initial metal ion-dependent noncovalent interaction between TSG-6 and HCs (also requiring an HC-associated Mg2+). The Link module HA-binding site is not required for HC transfer onto HA; only TSG-6 transferase activity (not HA binding) is essential for COC expansion.\",\n      \"method\": \"Crystal structure determination of CUB module, TSG-6 mutant analysis (transferase-impaired and HA-binding-impaired), in vitro COC expansion assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis and functional reconstitution in COC expansion assay\",\n      \"pmids\": [\"26468290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TSG-6 in muscle injury microenvironments is required for MSC engraftment: TSG-6 produced by MSCs in response to injury signals (C2C12 myotube lysate) promotes formation of SHAP-HA complexes (covalent HC·HA) that are required for MSC settlement in skeletal muscle; TSG-6 shRNA knockdown prevents settlement.\",\n      \"method\": \"Mouse MSC transplantation model, TSG-6 shRNA knockdown, immunofluorescence co-localization of HA/IαI/TSG-6, in vitro stimulation with C2C12 lysate\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — shRNA knockdown with in vivo transplantation functional readout\",\n      \"pmids\": [\"26178374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TSG-6 (via its Link module) binds multiple CC and CXC chemokines (CXCL4, CXCL8, CXCL11, CXCL12, CCL2, CCL5, CCL7, CCL19, CCL21, CCL27; KD 1–85 nM) at their GAG-binding sites, and also masks cell-surface GAGs, thereby broadly inhibiting chemokine presentation on endothelial cells and impairing GAG-dependent chemokine function.\",\n      \"method\": \"Surface plasmon resonance (KD measurement), chemokine-GAG competition assays, endothelial cell chemokine presentation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative binding measurements combined with functional inhibition assays across a panel of chemokines\",\n      \"pmids\": [\"27044744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TSG-6 inhibits TLR4-MyD88 association in macrophages, suppresses NF-κB activation, STAT1, and STAT3 activation, converts macrophages from proinflammatory to anti-inflammatory phenotype, and TSG-6-knockout mice show markedly augmented LPS-induced lung injury; LPS itself upregulates TSG-6 expression, suggesting an autocrine negative feedback loop.\",\n      \"method\": \"TSG-6−/− mice (LPS lung injury model), co-immunoprecipitation (TLR4-MyD88 association), macrophage phenotype markers, NF-κB/STAT Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse combined with co-IP and multiple molecular pathway analyses\",\n      \"pmids\": [\"27911817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IDO metabolite kynurenic acid (KYNA) produced by MSCs activates the aryl hydrocarbon receptor (AhR), which directly binds to the TSG-6 promoter and enhances TSG-6 expression; thus IDO controls TSG-6-mediated immunosuppression via the IDO→KYNA→AhR→TSG-6 axis.\",\n      \"method\": \"IDO deletion/inhibition in human MSCs, KYNA production inhibition, AhR activation assays, chromatin immunoprecipitation (AhR binding to TSG-6 promoter), mouse ALI model\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct AhR binding to TSG-6 promoter, supported by pharmacological and genetic perturbations\",\n      \"pmids\": [\"29238069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TSG-6 controls epithelial-mesenchymal transition (EMT) of proximal tubular epithelial cells: TGFβ1 induces TSG-6 expression and causes HA cable disassembly with formation of dense pericellular HA coats; stable knockdown of TSG-6 increases E-cadherin, prevents α-SMA induction, disrupts HA macromolecular structure, and slows cell migration, demonstrating TSG-6 is required for TGFβ1-mediated EMT via HA reorganization and CD44-dependent signaling.\",\n      \"method\": \"Stable shRNA knockdown, CD44 siRNA, TGFβ1 stimulation, immunolocalization of HA, cell migration assay, Western blot for EMT markers\",\n      \"journal\": \"International journal of biochemistry & cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — stable knockdown with receptor (CD44) siRNA validation and multiple functional readouts\",\n      \"pmids\": [\"21864707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TSG-6 knockdown by siRNA in fibroblasts upregulates MMP-1 and MMP-3 transcription and triggers extracellular active MMP-1 expression, demonstrating that TSG-6 normally suppresses MMP-1 transcription and prevents MMP-1 activation; this was further enhanced by IL-1β in TSG-6-deficient cells.\",\n      \"method\": \"TSG-6 siRNA knockdown in human conjunctival fibroblasts, qRT-PCR, Western blot, immunostaining of TSG-6/MMP-1/MMP-3\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown with transcriptional and protein-level readouts of MMP regulation\",\n      \"pmids\": [\"22297496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Matrix stiffness mechanosensitively regulates TSG-6 expression in MSCs through MAPK and Hippo signaling pathways and the downstream AP1 transcription factor complex; TSG-6 produced from MSCs on soft matrices then acts on macrophages through CD44 receptor to inhibit NF-κB pathway and promote anti-inflammatory polarization.\",\n      \"method\": \"MSC culture on hydrogels of varying stiffness, MAPK/Hippo pathway inhibitors, AP1 inhibitors, CD44 receptor studies, macrophage polarization assays, subcutaneous implantation in vivo\",\n      \"journal\": \"Acta biomaterialia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with in vitro and in vivo validation, but primarily from a single group\",\n      \"pmids\": [\"35820593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TSG-6 in colorectal cancer cells stabilizes CD44 and facilitates CD44-EGFR complex formation on the cell membrane, activating ERK signaling and epithelial-mesenchymal transition to promote migration/invasion; secreted TSG-6 also triggers paracrine JAK2-STAT3 signaling to reprogram normal fibroblasts into cancer-associated fibroblasts that upregulate CCL5 and MMP3.\",\n      \"method\": \"TSG-6 overexpression/knockdown in CRC cells, co-immunoprecipitation (CD44-EGFR complex), ERK/STAT3 Western blot, in vitro migration/invasion assays, co-injection xenograft model\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and signaling pathway analysis with functional tumor model, single study\",\n      \"pmids\": [\"35280699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-214-5p was identified as a negative regulator of TSG-6 mRNA in adipose-derived stem cells; TNFα stimulation of ADSCs upregulates TSG-6 (overriding miR-214-5p repression), and ADSC-derived TSG-6 inhibits LPS-induced proinflammatory cytokine production in BV2 microglia.\",\n      \"method\": \"High-throughput RNA sequencing, bioinformatics, microRNA-target identification, TSG-6/cytokine ELISA\",\n      \"journal\": \"BioMed research international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — bioinformatics-identified miRNA with limited functional validation of the miR-214-5p → TSG-6 link\",\n      \"pmids\": [\"30584538\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TNFAIP6/TSG-6 is a TNF/IL-1-inducible secreted glycoprotein (transcriptionally regulated via NF-IL6, AP-1, and AhR elements in its promoter) that functions as a multi-ligand extracellular matrix organizer and broad-spectrum anti-inflammatory mediator: its Link module binds hyaluronan (pH-dependently, maximally at pH 6.0 via stacking and ionic contacts), chondroitin sulfates, heparin, and multiple CC/CXC chemokines at their GAG-binding sites, thereby inhibiting chemokine presentation and neutrophil extravasation; its CUB module contains a Ca2+-binding site that, together with a HC2-dependent co-factor mechanism, catalyzes metal ion-dependent transesterification of heavy chains from inter-alpha-inhibitor first onto TSG-6 then onto HA to form covalent HC·HA complexes that stabilize extracellular matrices during inflammation and ovulation; full-length TSG-6 undergoes HA-induced oligomerization to cross-link HA matrices; TSG-6 signals through CD44 on macrophages and microglia to suppress TLR4/NF-κB and STAT signaling pathways; it directly inhibits RANKL-induced osteoclastogenesis and BMP-2-mediated osteoblastogenesis by binding these ligands; and its expression is upregulated in MSCs through an IDO→kynurenic acid→AhR→TSG-6 promoter axis, explaining much of the immunomodulatory paracrine activity of mesenchymal stem cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TNFAIP6 (TSG-6) is a TNF-α/IL-1-inducible secreted glycoprotein that functions as a broad-spectrum anti-inflammatory mediator and extracellular matrix organizer, acting through its Link and CUB modules to bind hyaluronan, multiple glycosaminoglycans, and chemokines, and to catalyze covalent heavy chain transfer onto hyaluronan. The Link module binds hyaluronan with pH-dependent affinity (maximal at pH 6.0, mediated by His4-controlled conformational switching), and also directly binds CC/CXC chemokines (CXCL8, CCL2, CCL5, and others at nanomolar affinity) at their GAG-binding sites, blocking chemokine presentation on endothelial surfaces and suppressing neutrophil extravasation [PMID:17307731, PMID:27044744, PMID:15457471]. The CUB module contains a Ca²⁺-binding site essential for metal ion-dependent transesterification that transfers inter-α-inhibitor heavy chains first onto TSG-6 then onto HA—a catalytic cycle requiring HC2 as obligate cofactor—to form covalent HC·HA matrices critical for cumulus-oocyte complex expansion and tissue remodeling [PMID:15840581, PMID:26468290, PMID:18448433]. TSG-6 additionally signals through CD44 on macrophages and microglia to suppress TLR4/NF-κB and STAT pathways, directly binds RANKL and BMP-2 to inhibit osteoclastogenesis and osteoblastogenesis, and constitutes a principal effector of MSC-mediated immunomodulation through an IDO→kynurenic acid→AhR→TSG-6 promoter axis [PMID:27911817, PMID:18586671, PMID:19570514, PMID:29238069].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing that TSG-6 is a primary-response gene transcriptionally activated by TNF-α and IL-1 answered the foundational question of how TSG-6 is induced during inflammation, identifying NF-IL6 and AP-1 promoter elements as the regulatory mechanism.\",\n      \"evidence\": \"Nuclear run-on, promoter deletion/reporter assays in human fibroblasts\",\n      \"pmids\": [\"8454591\", \"7876106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full enhancer architecture not mapped\", \"Post-transcriptional regulation largely unexplored at this stage\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that TSG-6 forms a stable covalent complex with inter-α-inhibitor (IαI) and that its Link module binds hyaluronan and chondroitin-4-sulfate established TSG-6 as a bifunctional molecule bridging serine protease inhibition and extracellular matrix glycosaminoglycan binding.\",\n      \"evidence\": \"Biochemical complex isolation, microtiter plate binding assays with competition experiments\",\n      \"pmids\": [\"9244409\", \"9237673\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic mechanism of HC transfer unknown\", \"Structural basis of HA recognition unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"NMR mapping of the HA-binding groove on the Link module and ITC-measured affinities resolved which residues mediate HA recognition, revealing a mechanism based on CH-π stacking with sugar rings and ionic contacts with glucuronic acids.\",\n      \"evidence\": \"NMR chemical shift perturbation and isothermal titration calorimetry with HA oligomers\",\n      \"pmids\": [\"10903951\", \"15718240\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"pH dependence mechanism not yet molecularly defined\", \"Role of CUB module in HA binding unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing that the Link module alone inhibits neutrophil migration in vivo independently of HA binding or IαI potentiation revealed a distinct anti-inflammatory mechanism separable from matrix-organizing functions.\",\n      \"evidence\": \"Site-directed mutagenesis of Link module, murine air pouch model, chimeric CD44/TSG-6 flow assays\",\n      \"pmids\": [\"12401803\", \"12011075\", \"15513871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target on neutrophils not identified\", \"Chemokine-binding mechanism not yet discovered\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"TSG-6 knockout mice with enhanced neutrophil infiltration and more severe arthritis provided genetic proof that endogenous TSG-6 is a non-redundant anti-inflammatory factor in vivo.\",\n      \"evidence\": \"TSG-6 KO mouse with proteoglycan-induced arthritis and thioglycollate peritonitis models\",\n      \"pmids\": [\"15457471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of neutrophil extravasation inhibition not fully defined\", \"Contribution of different TSG-6 activities (HA cross-linking vs. protease inhibition) not dissected in vivo\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Reconstitution of the two-step transesterification reaction—HC transfer from IαI chondroitin sulfate onto TSG-6, then from TSG-6 onto HA—established TSG-6 as a catalytic transferase recycled after HC·HA formation, resolving the enzymatic mechanism of covalent matrix assembly.\",\n      \"evidence\": \"In vitro reconstitution with purified IαI and recombinant TSG-6, metal ion manipulation, SDS-PAGE\",\n      \"pmids\": [\"15840581\", \"16768462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Active-site residues not identified\", \"Structural basis of metal ion requirement unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of His4 as the pH sensor controlling HA affinity—its deprotonation above pH 6.0 disrupts a buried salt bridge network propagating to HA-binding residue Tyr12—provided a molecular explanation for how TSG-6 activity is tuned by inflammatory acidosis.\",\n      \"evidence\": \"Site-directed mutagenesis, NMR pKa determination, ITC\",\n      \"pmids\": [\"17307731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of pH switching not directly tested\", \"Allostery between heparin and HA sites only partially characterized\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Crystal structure and NMR dynamics of the Link module revealed that HA-binding loops are mobile in the free state and rigidified upon HA binding, and that HA binding allosterically dampens mobility at the heparin-binding site, providing structural evidence for functional crosstalk between binding surfaces.\",\n      \"evidence\": \"X-ray crystallography and ¹⁵N NMR relaxation\",\n      \"pmids\": [\"17585936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length TSG-6 structure not determined\", \"Structural basis of CUB-Link interplay unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Discovery that HC2 is an obligate cofactor for HC transfer from bikunin-family proteins onto HA defined a specificity checkpoint in the transesterification pathway, and demonstration that TSG-6 inhibits both RANKL-mediated osteoclastogenesis and BMP-2-mediated osteoblastogenesis expanded TSG-6's functional scope to bone remodeling.\",\n      \"evidence\": \"In vitro reconstitution with purified HC components; osteoclast/osteoblast differentiation assays and TSG-6 KO mouse bone phenotype\",\n      \"pmids\": [\"18448433\", \"18586671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of RANKL/BMP-2 binding not resolved\", \"HC2 cofactor mechanism at molecular level unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showing that TSG-6 knockdown in MSCs abolishes cardiac repair after myocardial infarction—and that recombinant TSG-6 alone replicates the effect—identified TSG-6 as a principal paracrine effector of MSC immunotherapy.\",\n      \"evidence\": \"TSG-6 siRNA in hMSCs, recombinant TSG-6 rescue, mouse MI model\",\n      \"pmids\": [\"19570514\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling mechanism in cardiac tissue not defined\", \"Relative contribution of different TSG-6 activities in cardiac protection unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"TSG-6 was shown to signal through CD44 on macrophages to suppress NF-κB nuclear translocation, and full-length TSG-6 was found to oligomerize on HA and cross-link HA matrices—establishing two mechanistically distinct functions: receptor-mediated signaling and physical matrix organization.\",\n      \"evidence\": \"Zymosan peritonitis model with CD44 interaction studies; QCM-D/AFM on end-grafted HA films\",\n      \"pmids\": [\"21551236\", \"21596748\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Oligomerization interface on TSG-6 not structurally defined\", \"Whether CD44 signaling requires HA cross-linking not determined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Quantitative demonstration that TSG-6 directly binds CXCL8 and a panel of CC/CXC chemokines at nanomolar affinity via their GAG-binding sites resolved the long-standing question of how TSG-6 inhibits neutrophil extravasation: by sequestering chemokines and blocking their endothelial presentation.\",\n      \"evidence\": \"SPR binding measurements, neutrophil transendothelial migration assays, chemokine-GAG competition\",\n      \"pmids\": [\"24501198\", \"27044744\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative in vivo contribution of chemokine sequestration versus other anti-inflammatory mechanisms not quantified\", \"Selectivity determinants for different chemokines not structurally resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structure of the CUB module revealed the Ca²⁺-binding site mediating HC·TSG-6 intermediate formation and showed that HC transfer onto HA (but not HA binding) is the essential TSG-6 function for cumulus-oocyte complex expansion.\",\n      \"evidence\": \"CUB module crystal structure, transferase-impaired and HA-binding-impaired mutants in COC expansion assay\",\n      \"pmids\": [\"26468290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length TSG-6 structure\", \"Atomic details of HC–CUB interaction unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"TSG-6 was found to disrupt TLR4-MyD88 association and suppress STAT1/STAT3 signaling in macrophages, and TSG-6 KO mice showed markedly augmented LPS-induced lung injury, defining a TLR4-level signaling checkpoint and confirming an autocrine negative feedback loop.\",\n      \"evidence\": \"TSG-6 KO mouse LPS lung injury model, co-immunoprecipitation of TLR4-MyD88\",\n      \"pmids\": [\"27911817\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding site on TLR4 or MyD88 not identified\", \"Whether TSG-6 acts on TLR4 directly or via CD44/HA intermediates not fully resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"ChIP demonstrated that AhR directly binds the TSG-6 promoter downstream of IDO-generated kynurenic acid, establishing a transcriptional axis (IDO→KYNA→AhR→TSG-6) that explains how MSC immunosuppression is metabolically regulated.\",\n      \"evidence\": \"ChIP for AhR on TSG-6 promoter, IDO deletion/inhibition in MSCs, mouse ALI model\",\n      \"pmids\": [\"29238069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AhR element cooperates with NF-IL6/AP-1 elements not tested\", \"Relevance of this axis outside MSC biology not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Matrix stiffness was shown to regulate TSG-6 expression through MAPK/Hippo/AP1 signaling, and TSG-6 in colorectal cancer was found to stabilize CD44, promote CD44-EGFR complex formation, and activate ERK/STAT3 signaling—revealing that TSG-6's CD44-dependent functions can be co-opted in cancer.\",\n      \"evidence\": \"Hydrogel stiffness variation with pathway inhibitors; CRC cell TSG-6 overexpression/knockdown with co-IP and xenograft\",\n      \"pmids\": [\"35820593\", \"35280699\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cancer-associated TSG-6 functions from single studies, not independently replicated\", \"Whether TSG-6-CD44-EGFR complex reflects a general mechanism or is cancer-specific is unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"No full-length TSG-6 structure exists; the atomic basis of Link-CUB module cooperation during HC transesterification, the structural determinants of TSG-6 oligomerization on HA, and the precise mechanism by which TSG-6 disrupts TLR4-MyD88 signaling remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length structure needed to understand inter-module allostery\", \"TSG-6 oligomerization interface not defined\", \"Direct versus CD44/HA-mediated action on TLR4 signaling not resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [12, 16, 22, 33]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3, 4, 5, 14, 15, 17]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 26, 30, 35, 36]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [12, 16, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [6, 25, 28, 34]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [6, 25, 34]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 11, 24, 30, 35, 36]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [6, 12, 25, 28, 34]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [24, 32, 36, 40, 41]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [6, 33]}\n    ],\n    \"complexes\": [\n      \"IαI·TSG-6 (HC·TSG-6 covalent intermediate)\",\n      \"HC·HA complex\"\n    ],\n    \"partners\": [\n      \"ITIH1\",\n      \"ITIH2\",\n      \"CD44\",\n      \"THBS1\",\n      \"TNFSF11\",\n      \"BMP2\",\n      \"CXCL8\",\n      \"TLR4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}